Zacks Investment Management Vertex Pharmaceuticals Inc Transaction History

Zacks Investment Management

$11.4 Billion
Q3 2024

A detailed history of Zacks Investment Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Zacks Investment Management holds 62,484 shares of VRTX stock, worth $24.8 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

62,484

Previous 59,765 4.55%

Holding current value

$24.8 Million

Previous $28 Million 3.74%

% of portfolio

0.25%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $1.25 Million - $1.38 Million	2,719 Added 4.55%	62,484 $29.1 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $2.13 Million - $2.64 Million	5,432 Added 10.0%	59,765 $28 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $21.9 Million - $23.9 Million	53,662 Added 7997.32%	54,333 $22.7 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $230,153 - $275,566	671 New	671 $273,000
Q2 2023 Aug 15, 2023	BUY	$314.42 - $351.91 $384,850 - $430,737	1,224 New	1,224 $430,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $3.69 Million - $4.21 Million	-13,031 Reduced 88.74%	1,654 $521,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $298,047 - $335,303	1,043 Added 7.65%	14,685 $4.24 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $4.29 Million - $4.78 Million	-15,649 Reduced 53.43%	13,642 $3.95 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $88,344 - $109,998	376 Added 1.3%	29,291 $8.25 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $6.4 Million - $7.55 Million	28,915 New	28,915 $7.55 Million
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $221,793 - $279,982	-1,253 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $5.48 Million - $6.13 Million	-30,207 Reduced 96.02%	1,253 $227,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $1.54 Million - $1.81 Million	-8,190 Reduced 20.66%	31,460 $6.34 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $2.26 Million - $2.63 Million	10,903 Added 37.93%	39,650 $8.52 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $1.74 Million - $2.32 Million	-8,417 Reduced 22.65%	28,747 $6.79 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $1.97 Million - $2.34 Million	-7,711 Reduced 17.18%	37,164 $10.1 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $572,268 - $750,740	2,538 Added 5.99%	44,875 $13 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $2.12 Million - $2.63 Million	10,610 Added 33.44%	42,337 $10.1 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $272,904 - $366,540	1,637 Added 5.44%	31,727 $6.95 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $5 Million - $5.63 Million	30,090 New	30,090 $5.1 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $1.09 Million - $1.23 Million	-7,937 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $1.18 Million - $1.29 Million	7,937	7,937 $1.21 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Account

Zacks Investment Management Vertex Pharmaceuticals Inc Transaction History